News | December 28, 2011

New Zealand Hospital Displays Success of Varian TrueBeam System

December 28, 2011 — Clinicians at one of New Zealand's leading hospitals have delivered more than 300 radiotherapy treatments using a newly installed TrueBeam device, from Varian Medical Systems, in the first month of its implementation. The system adds to Wellington Hospital's radiotherapy capabilities and enables fast, precise and efficient treatments.

The first patient in the country — and the southern hemisphere — to be treated with the device was an 18-year-old man with Hodgkin's disease. "He commented on the speed with which the treatment was delivered and was enthusiastic to be our first patient treated on TrueBeam," says Jennifer de Ridder, radiation therapist team leader at Wellington Hospital. "Many of our patients have commented on the speed of their treatments, which is a significant factor for those who are immobilized during treatment."

To manage treatment waiting times in New Zealand, the government recently introduced a target that all patients should commence radiotherapy within four weeks of a decision to treat. "We usually meet this target but need to be more efficient to continue meeting it in future," says Carole Johnson, clinical leader of radiation oncology. "So more advanced treatment techniques must be incorporated without making treatment slots longer and without impacting our ability to meet this waiting time target. TrueBeam helps us to achieve this."

The device at Wellington replaces a 14-year-old treatment machine and enables the hospital to expand its range of radiotherapy treatments; this includes intensity modulated radiotherapy, image-guided radiotherapy, RapidArc volumetric radiotherapy and, in the future, stereotactic radiotherapy.

The TrueBeam platform is a fully integrated radiotherapy system for image-guided radiotherapy and radiosurgery, designed to treat a moving target with speed and precision. It can be used to improve the treatment of lung, breast, prostate, head and neck cancer, among other types. It features a High Intensity Mode—one of six dose levels available to doctors—for customizing dose delivery based on a patient's specific tumor characteristics.

"In addition to improving workflow at the hospital, TrueBeam will enable us to introduce stereotactic body radiotherapy treatments for selected patients in 2012," says Lynne Greig, chief medical physicist. "It clearly positions us for the future while integrating easily with our existing suite of equipment."

Wellington Hospital treats 1,300 patients each year, providing external beam and high dose rate brachytherapy radiation treatments using Varian equipment and software. It is one of just eight radiotherapy departments in the country.

For more information: www.varian.com

 

Related Content

Mevion Receives 510(k) Clearance for Hyperscan Pencil Beam Scanning Proton Therapy
Technology | Proton Therapy | January 04, 2018
Mevion Medical Systems has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the Mevion S250i...
Study Compares Radiosurgery and Whole-Brain Radiation in Lung Cancer Patients With Multiple Brain Metastases
News | Radiation Therapy | January 03, 2018
Although targeted therapies have produced dramatic advances in the ability to control some types of advanced lung...
MEDraysintell Downgrades Proton Therapy Market Projection for 2030
News | Proton Therapy | January 02, 2018
MEDraysintell recently downgraded its projection for proton therapy rooms expected to be operational in 2030 from 1,200...
California US Oncology Network Centers Adopt Xoft Electronic Brachytherapy System for Early-Stage Non-Melanoma Skin Cancer
News | Brachytherapy Systems | January 02, 2018
iCAD Inc. announced that its Xoft Axxent Electronic Brachytherapy (eBx) System is now available at two California-based...
Blue Phantom System Used for Acceptance of First European Varian Halcyon Machine
News | Radiation Therapy | January 02, 2018
IBA (Ion Beam Applications S.A.) announced in November the acceptance and beam model validation of the first Varian...
Study Finds Link Between Breast Cancer Treatments and Cellular Aging Markers
News | Women's Health | January 02, 2018
January 2, 2018 — A new study found women who had received chemotherapy and/or...
ACR Appropriateness Criteria Adds and Revises Topics for December 2017
News | Clinical Decision Support | December 29, 2017
December 29, 2017 — Radiologists can enhance the quality and effectiveness of care with the newest release of the ACR
FDA Clears GammaPod Stereotactic Radiotherapy System for Breast Cancer Treatment
Technology | Stereotactic Body Radiation Therapy (SBRT) | December 22, 2017
The U.S. Food and Drug Administration (FDA) has cleared the new GammaPod noninvasive stereotactic radiotherapy system...
RaySearch Launches RayCare Oncology Information System

Image courtesy of RaySearch Laboratories

Technology | Oncology Information Management Systems (OIMS) | December 22, 2017
RaySearch announced the first release of RayCare, a new oncology information system (OIS) designed to connect the...
RaySearch Releases RayStation 7 Radiotherapy Treatment Planning System
Technology | Treatment Planning | December 19, 2017
RayStation 7, the latest release of RaySearch’s radiation therapy treatment planning system, adds new functionality and...
Overlay Init